Bipolar Disorder
📧 Sign up to get email alerts when something new happens for Bipolar Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2016-12-08Clinical Trial Update: Magnesium Variations and Cardiometabolic Risk in Patients With Antipsychotic Drugs [NA]
A clinical trial update examining how magnesium variations relate to cardiometabolic risk in patients taking antipsychotic medications.
-
FDA approval · 2016-11-30FDA Approved: LAMOTRIGINE — Supplemental Application (Dr.Reddy's Laboratories Limited)
The FDA approved a supplemental application for Lamotrigine from Dr. Reddy's Laboratories Limited.
-
CLINICAL_TRIALS trial_result · 2016-11-28Clinical Trial Update: NACOS - The Effect of N-acetylcystein for Depressive Symptoms in Patients Suffering From Bipolar Depression [Phase 2]
A Phase 2 trial evaluating the effect of N-acetylcysteine on depressive symptoms in bipolar disorder has completed.
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Prevention of Mood Disorders by Folic Acid Supplementation [NA]
A completed University of Oxford clinical trial evaluating whether folic acid supplementation can prevent mood disorders, including major de…
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc., resulting in changes to the …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2016-11-08FDA Approved: CARBAMAZEPINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for carbamazepine submitted by Sun Pharmaceutical Industries, Inc.
-
CLINICAL_TRIALS trial_result · 2016-11-08Clinical Trial Update: Contingency Management of Psychostimulant Abuse in the Severely Mentally Ill [NA]
A completed clinical trial evaluating contingency management for stimulant use disorder in individuals with severe mental illness.
-
CLINICAL_TRIALS trial_result · 2016-11-07Clinical Trial Update: Light Therapy for Bipolar Disorder. Efficacy of Light Therapy for Bipolar Depression: A Randomized Controlled Trial [Phase 3]
Phase 3 randomized controlled trial evaluating the efficacy of light therapy for bipolar depression. Results were posted in 2016.
-
FDA approval · 2016-11-02FDA Approved: DEPAKOTE SPRINKLES — Supplemental Application (AbbVie Inc.)
FDA approved a Supplemental Application for Depakote Sprinkles (divalproex sodium) submitted by AbbVie Inc.
-
FDA approval · 2016-11-02FDA Approved: DEPAKOTE — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for Depakote (divalproex sodium) from AbbVie Inc. The action updates labeling or indications related…
-
FDA approval · 2016-11-01FDA Approved: QUETIAPINE FUMARATE — Original Application (Accord Healthcare Inc.)
The FDA approved Accord Healthcare Inc.'s original application for quetiapine fumarate, granting marketing authorization for a generic versi…
-
FDA approval · 2016-10-27FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for ZYPREXA INTRAMUSCULAR (olanzapine) by Eli Lilly and Company, resulting in updated labeling t…
-
FDA approval · 2016-10-25FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for lithium carbonate submitted by Hikma Pharmaceuticals USA Inc., resulting in changes to the a…
-
FDA approval · 2016-10-25FDA Approved: LITHIUM CARBONATE — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
FDA approved a supplemental application for Lithium Carbonate from Hikma Pharmaceuticals USA Inc.
-
FDA approval · 2016-10-18FDA Approved: ARIPIPRAZOLE — Supplemental Application (Torrent Pharmaceuticals Limited)
FDA approved a supplemental application for aripiprazole from Torrent Pharmaceuticals Limited, enabling a generic version of the drug.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: FMRI Study of Brain Response Before and After Lithium Treatment in People With Bipolar Disorder [Phase 4]
A Phase 4 clinical trial at Indiana University used fMRI to examine brain responses before and after lithium treatment in people with bipola…
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: Valproate Efficacy in Cocaine-Bipolar Comorbidity [Phase 1, Phase 2]
This clinical trial update reports completion of Phase 1 and Phase 2 studies assessing valproate for efficacy in individuals with bipolar di…
-
FDA approval · 2016-10-07FDA Approved: ARIPIPRAZOLE — Original Application (Macleods Pharmaceuticals Limited)
The FDA approved Macleods Pharmaceuticals Limited's generic aripiprazole (ANDA 204111) based on its original application.
-
FDA approval · 2016-10-06FDA Approved: ZYPREXA INTRAMUSCULAR — Supplemental Application (Eli Lilly and Company)
The FDA approved a supplemental application for Zyprexa Intramuscular (olanzapine) by Eli Lilly and Company to support the intramuscular for…
-
CLINICAL_TRIALS research · 2016-10-06Clinical Trial Update: Neurofunctional and Neurochemical Markers of Treatment Response in Bipolar Disorder [Phase 4]
This document provides a status update on a Phase 4 clinical trial assessing neurofunctional and neurochemical markers of treatment response…
-
CLINICAL_TRIALS trial_result · 2016-10-05Clinical Trial Update: Future Internet Social and Technological Alignment Research [NA]
A Basque Health Service–sponsored clinical trial related to Bipolar Disorder has completed; the summary indicates the status is COMPLETED wi…
-
CLINICAL_TRIALS trial_result · 2016-10-04Clinical Trial Update: Pilot Study Evaluating the Safety and Efficacy of Open-Label Olanzapine [Phase 3]
A Phase 3 open-label pilot study assessing the safety and efficacy of olanzapine in bipolar disorder was terminated.
-
CLINICAL_TRIALS trial_result · 2016-09-30Clinical Trial Update: Telemedicine for Women With Anhedonia in Bipolar and Unipolar Disorder [NA]
ClinicalTrials.gov update indicates the completion of a telemedicine study examining anhedonia in women with bipolar and unipolar depression…
-
FDA approval · 2016-09-29FDA Approved: LITHIUM CARBONATE — Original Application (Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.)
The FDA approved the original application for a generic lithium carbonate product. The approval enables commercialization by Heritage Pharma…
-
FDA approval · 2016-09-29FDA Approved: ARIPIPRAZOLE — Original Application (Dr.Reddys Laboratories Inc)
FDA approves Dr. Reddy's Laboratories' generic aripiprazole under an original ANDA application. This action provides a generic option for th…